Showing results (321-330 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|September 24, 2004
Peptide-mediated delivery of therapeutic and imaging agents into mammalian cellsMichael Stefanidakis, Erkki KoivunenCurrent Pharmaceutical Design|September 24, 2004
Novel ligands: fine tuning the transcriptional activity of the glucocorticoid receptorM Schulz, M EggertCurrent Pharmaceutical Design|September 24, 2004
The role of STATs in inflammation and inflammatory diseasesE Pfitzner, S Kliem, D Baus, et al.Current Pharmaceutical Design|November 17, 2004
Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agentsD K Lahiri, J T Rogers, N H Greig, et al.Current Pharmaceutical Design|November 17, 2004
Vasoactive renal factors and the progression of diabetic nephropathyLesley Wassef, Robyn G Langham, Darren J KellyCurrent Pharmaceutical Design|November 17, 2004
Lipoproteins and diabetic microvascular complicationsA J Jenkins, K G Rowley, T J Lyons, et al.Current Pharmaceutical Design|November 17, 2004
Can an apple a day keep the doctor away?Ilya Raskin, Christophe RipollCurrent Pharmaceutical Design|November 17, 2004
Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitorsKazuhiro Tateda, Theodore J Standiford, Jean Claude Pechere, et al.Current Pharmaceutical Design|November 17, 2004
Liposome technology for drug delivery against mycobacterial infectionsG K Khuller, Manisha Kapur, Sadhna SharmaCurrent Pharmaceutical Design|November 17, 2004
Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathyJosephine M Forbes, Vicki Thallas-Bonke, Mark E Cooper, et al.Pageof 1,006